Abstract

Phosphoproteomics is a cutting-edge technique that can be utilized to explore adipose tissue (AT) metabolism by quantifying the repertoire of phospho-peptides (PP) in AT. Dairy cows were supplemented with conjugated linoleic acid (CLA, n = 5) or a control diet (CON, n = 5) from 63 d prepartum to 63 d postpartum; cows were slaughtered at 63 d postpartum and AT was collected. We performed a quantitative phosphoproteomics analysis of subcutaneous (SC) and omental (OM) AT using nanoUPLC-MS/MS and examined the effects of CLA supplementation on the change in the phosphoproteome. A total of 5919 PP were detected in AT, and the abundance of 854 (14.4%) were differential between CON and CLA AT (p ≤ 0.05 and fold change ± 1.5). The abundance of 470 PP (7.9%) differed between OM and SC AT, and the interaction treatment vs. AT depot was significant for 205 PP (3.5% of total PP). The integrated phosphoproteome demonstrated the up- and downregulation of PP from proteins related to lipolysis and lipogenesis, and phosphorylation events in multiple pathways, including the regulation of lipolysis in adipocytes, mTOR signaling, insulin signaling, AMPK signaling, and glycolysis. The differential regulation of phosphosite on a serine residue (S777) of fatty acid synthase (FASN) in AT of CLA-supplemented cows was related to lipogenesis and with more phosphorylation sites compared to acetyl-coenzyme A synthetase (ACSS2). Increased protein phosphorylation was seen in acetyl-CoA carboxylase 1 (ACACA;8 PP), FASN (9 PP), hormone sensitive lipase (LIPE;6 PP), perilipin (PLIN;3 PP), and diacylglycerol lipase alpha (DAGLA;1 PP) in CLA vs. CON AT. The relative gene expression in the SC and OM AT revealed an increase in LIPE and FASN in CLA compared to CON AT. In addition, the expression of DAGLA, which is a lipid metabolism enzyme related to the endocannabinoid system, was 1.6-fold higher in CLA vs. CON AT, and the expression of the cannabinoid receptor CNR1 was reduced in CLA vs. CON AT. Immunoblots of SC and OM AT showed an increased abundance of FASN and a lower abundance of CB1 in CLA vs. CON. This study presents a complete map of the SC and the OM AT phosphoproteome in dairy cows following CLA supplementation and discloses many unknown phosphorylation sites, suggestive of increased lipid turnover in AT, for further functional investigation.

Highlights

  • Phosphoproteomics is a new, cutting-edge technique that can reveal the effect of a nutritional manipulation on the activity of proteins in a tissue [1]

  • The phosphoproteomic strategy focused on quantitative mass spectrometry (MS) and was adopted to recognize and characterize changes in phosphorylation in dairy cows supplemented with conjugated linoleic acid (CLA) vs. control (CON), and to compare the phosphoproteome of SC and OM adipose tissue (AT)

  • We found an enrichment of the lipid metabolism pathways in AT, lipogenesis and lipolysis, which could suggest an increased lipid turnover in AT and explain the metabolic response to CLA supplementation; these data add important new information on specific PP that are affected by CLA

Read more

Summary

Introduction

Phosphoproteomics is a new, cutting-edge technique that can reveal the effect of a nutritional manipulation on the activity of proteins in a tissue [1]. Research in rodents and humans has suggested that CLA could act to reduce adiposity through modulating properties in the lipid metabolism in AT [4,5]. Different AT depots react differently to metabolic stimuli [14], and studies in dairy cows suggest that subcutaneous (SC) and internal AT depots may have different metabolic properties [15,16,17], the response to CLA supplementation may be different in omental (OM) and SC AT. CLA reduces body fat by altering gene expression, inhibiting cell differentiation, and altering the activity of proteins involved in lipogenesis and lipolysis [18]. Studies have linked CLA with reduction in milk fat synthesis in dairy cows [20] and increased inflammation and insulin resistance in rodents and humans [21,22]. CLA supplementation would be expected to increase AT lipolysis, reduce the activity of LPL, and increase carnitine-palmitoyl-transferase-1 (CAT-1) activity in AT

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call